Illumina Wins Bid To Block BGI Genomics' DNA Product Sales
Illumina has scored a victory in its patent battle against Chinese genetics company BGI Genomics, with a California federal judge issuing a ban against BGI's DNA sequencing products, despite arguments that...To view the full article, register now.
Already a subscriber? Click here to view full article